Is L&P Cosmetic (Mediheal) profitable in 2026?

No audited profit figures are public. Reported revenue was about 300 billion won (~$220M) in FY2024, up 54% YoY per Maeil Business Newspaper, March 19, 2025, with three straight years of double-digit growth, but net profitability has not been independently verified.

Could L'Oréal or Amorepacific just copy Mediheal's sheet masks?

Yes. Mediheal's core products, sheet masks and toner pads, are physical goods with no patent or regulatory barrier verified. Incumbents like L'Oréal, Estee Lauder (Dr. Jart+), Amorepacific and Shiseido already sell directly competing derma-cosmetics in the same Korean and US retail channels.

Is Mediheal expanding into the US market?

Yes. As of February 11, 2026 Mediheal's PDRN Collection launched nationwide across 1,400+ Ulta Beauty doors, plus Target and Costco distribution, and it debuted at the first US Olive Young store in Pasadena, CA on June 2, 2026.

Is Biodance a real threat to Mediheal's Olive Young lead?

Biodance is a fast-rising Korean sheet-mask and collagen brand competing directly with Mediheal on Olive Young shelves as of 2026. Mediheal has held the #1 sales spot at Olive Young for 2024 and 2025, but that ranking has no structural protection against a rising challenger.

Is there legal trouble at L&P Cosmetic?

Yes. On June 3, 2026 an early 2012 investor who put in 400 million won lost an appeal in a 6.4 billion won lawsuit against L&P Cosmetic over a disputed revenue-share pledge, per Seoul Economic Daily reporting.

Is L&P Cosmetic going public soon?

No confirmed IPO exists as of mid-2026. Speculation about a KOSPI listing circulates in vendor-authored sources referencing late 2025 to 2026 timing, but no filing has been confirmed by primary reporting or exchange disclosure.

South Korea · South Korea

L&P Cosmetic

South Korean sheet mask and derma-cosmetics brand (Mediheal), sold via Olive Young, Ulta, Target, Costco.

Losing its protection

Assessed 29 July 2026 · Evidence as of 29 July 2026

The structural protection is eroding.

On the recordSince 29 July 2026 · Checkable from Q2 2027 · Every call on the record Checkpoint: Next Olive Young annual brand ranking cycle and Ulta PDRN sell through check

The call

Mediheal is growing fast on real shelf space, but nothing stops Amorepacific, Estee Lauder, or Biodance from copying the same masks on the same shelves.

L&P Cosmetic makes and sells sheet masks and skin treatments under the Mediheal brand, mostly in Korea but expanding to Ulta and Target in the US. It is easy for giant competitors like L'Oréal, Estée Lauder, and Amorepacific to copy sheet masks and sell them right next to Mediheal on the same shelf, and a newer rival called Biodance is already doing this. The company's entire value depends on staying trendy and staying popular with shoppers, which can change quickly if customers switch to a different brand.

Why

AI pressure: L'Oreal ModiFace AI skin diagnostics. AI skin scanners could steer shoppers to whichever brand's app they open first, not a direct product substitute yet. Could AI do the core job? Unlikely.

Bigger players: Amorepacific, Estee Lauder (Dr. Jart+), L'Oreal, Shiseido, and fast rising domestic rival Biodance. All of these already sell sheet masks and derma-cosmetics on the same Olive Young and Ulta shelves as Mediheal. Could a giant copy it? Yes, easily.

What protects it. Current #1 ranking at Olive Young for two years and built out US retail doors give it visibility rivals would need time to match.

What would change this call

Whether Mediheal keeps or loses #1 rank at Olive Young in the next ranking cycle. Shows if Biodance or another rival is actually taking its home-market lead.
Sell-through of the PDRN Collection across 1,400+ Ulta doors by Q2 2027. Shows if US retail growth is real demand or just shelf-count expansion.
Whether a KOSPI IPO is confirmed, priced, and trades stably post-listing. Shows if outside investors validate the growth story with real capital.

Key numbers

FY2024 revenue about $220M, up 54% YoY (2024)
#1 best selling brand at Olive Young, two years running (2025)
Over 1,400 Ulta Beauty doors carry Mediheal (2026-02)

Named risks

No structural moat; physical sheet-mask and toner-pad products easily replicated by larger incumbents. Severity: high
Ongoing legal exposure after losing June 2026 appeal in 6.4 billion won revenue-share lawsuit. Severity: medium
Category is trend-driven; sheet masks and toner pads could fall out of favor with shifting K-beauty trends. Severity: medium
US retail expansion (Ulta, Olive Young Pasadena) unproven at scale; American demand patterns differ from Asia. Severity: medium
Ownership and valuation data inconsistent across sources; no audited financials or confirmed IPO. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Biodance	gaining on	Fast-rising sheet-mask brand competing with Mediheal on Olive Young shelves, 2026
Amorepacific (Laneige, Innisfree)	contesting	Large Korean incumbent directly competing in same derma-cosmetic category
Estee Lauder (Dr. Jart+)	contesting	Owns competing K-beauty-style derma brand in same retail channels
L'Oreal	contesting	Deployed ModiFace AI skin diagnostic and Perso AI device by October 2024
Shiseido	contesting	Named as a global incumbent active in the sheet-face-mask category per 2026 market report

Questions people ask

Is L&P Cosmetic (Mediheal) profitable in 2026?: No audited profit figures are public. Reported revenue was about 300 billion won (~$220M) in FY2024, up 54% YoY per Maeil Business Newspaper, March 19, 2025, with three straight years of double-digit growth, but net profitability has not been independently verified.
Could L'Oréal or Amorepacific just copy Mediheal's sheet masks?: Yes. Mediheal's core products, sheet masks and toner pads, are physical goods with no patent or regulatory barrier verified. Incumbents like L'Oréal, Estee Lauder (Dr. Jart+), Amorepacific and Shiseido already sell directly competing derma-cosmetics in the same Korean and US retail channels.
Is Mediheal expanding into the US market?: Yes. As of February 11, 2026 Mediheal's PDRN Collection launched nationwide across 1,400+ Ulta Beauty doors, plus Target and Costco distribution, and it debuted at the first US Olive Young store in Pasadena, CA on June 2, 2026.
Is Biodance a real threat to Mediheal's Olive Young lead?: Biodance is a fast-rising Korean sheet-mask and collagen brand competing directly with Mediheal on Olive Young shelves as of 2026. Mediheal has held the #1 sales spot at Olive Young for 2024 and 2025, but that ranking has no structural protection against a rising challenger.
Is there legal trouble at L&P Cosmetic?: Yes. On June 3, 2026 an early 2012 investor who put in 400 million won lost an appeal in a 6.4 billion won lawsuit against L&P Cosmetic over a disputed revenue-share pledge, per Seoul Economic Daily reporting.
Is L&P Cosmetic going public soon?: No confirmed IPO exists as of mid-2026. Speculation about a KOSPI listing circulates in vendor-authored sources referencing late 2025 to 2026 timing, but no filing has been confirmed by primary reporting or exchange disclosure.

Timeline

2026-06-03Early 2012 investor loses appeal in 6.4 billion won revenue-share lawsuit against L&P
2026-06-02Mediheal launches at first US Olive Young store in Pasadena, CA
2026-02-11PDRN Collection rolls out nationwide across 1,400+ Ulta Beauty doors
2026-01-20Mediheal named #1 Olive Young brand for second straight year, 3.3B+ masks sold
2025-04-21Mediheal cites 300% sales surge from 2024 dermatology skincare line launch
2025-03-19FY2024 revenue reported at ~$220M, up 54% YoY, per Maeil Business Newspaper
2018-10-24Corporate Minority III funding round of $35.6M closes
2017-04Credit Suisse-led raise values L&P Cosmetic at approximately $1.78B
2009-04-01L&P Cosmetic founded in Seoul by Kwon Oh-sub

Revision history

29 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Kurly MEGAZONE RIDI